Cost-Effectiveness of Crizotinib for Second and Third-Line Treatment of Non-Small Cell Lung Cancer in Ecuador
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 71
(2)
◽
pp. 117-126
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. 9005-9005
◽
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
Vol 15
(5)
◽
pp. 343-357
◽
Keyword(s):